Lv4
540 积分 2023-07-07 加入
Cost-utility analysis of sotagliflozin for heart failure patients with diabetes in China
4个月前
已完结
Cost–utility analysis of sotagliflozin for heart failure patients with diabetes in China
4个月前
已完结
Cost-effectiveness of sotagliflozin for the treatment of patients with diabetes and recent worsening heart failure
4个月前
已关闭
Cost-Effectiveness of Sotagliflozin for the Treatment of Recent Worsening Heart Failure with Diabetes
4个月前
已关闭
EVALUATING THE COST-EFFECTIVENESS OF SOTAGLIFLOZIN IN HEART FAILURE PATIENTS WITH PRESERVED AND REDUCED EJECTION FRACTIONS: INSIGHTS FROM THE SOLOIST-WHF TRIAL
4个月前
已关闭
Cost-Effectiveness of Sotagliflozin in Heart Failure Patients With Preserved and Reduced Ejection Fractions-Results From the SOLOIST-WHF
4个月前
已关闭
COST-EFFECTIVENESS OF EMPAGLIFLOZIN VS DAPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETES MELLITUS AND ESTABLISHED CARDIOVASCULAR DISEASE IN THE UNITED STATES
4个月前
已完结
治疗Ⅱ型糖尿病的四种药物的成本-效果分析
4个月前
已完结
纳武利尤单抗和帕博利珠单抗治疗复发性或转移性头颈部鳞状细胞癌药物经济学系统性评价
4个月前
已完结
Predicting and preventing heart failure in type 2 diabetes
5个月前
已完结
皖公网安备34019202002308
